Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes

被引:9
作者
Turgut, M
Jellestad, FK
Mathisen, JR
Thorsen, T
Wester, K
Aakvag, A
机构
[1] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[2] Univ Bergen, Inst Physiol Psychol, N-5000 Bergen, Norway
[3] Univ Bergen, Inst Clin Biol, N-5021 Bergen, Norway
关键词
Parkinson's disease; substantia nigra; behaviour; sympathetic activity; 6-hydroxydopamine; rat;
D O I
10.1007/s004330050077
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the effects of experimental hemiparkinsonism upon sympathetic function in rat. The rats were divided into three groups: a group given intact control, one given lesioning with 6-hydroxydopamine (6-OHDA), and one given sham operation. One day after apomorphine testing following lesioning of the substantia nigra (SN) with 6-OHDA, heart rate (HR), mean arterial blood pressure (MAP), and electrocardiogram (EGG) were monitored. Plasma norepinephrine (NE), epinephrine (E), and dopamine (DA) levels were measured. Thereafter, immunohistochemical examination was performed to detect the extent of 6-OHDA lesions, using the avidinbiotinylated peroxidase complex (ABC) method. There was no difference in the total number of tyrosine hydroxylase (TH)-positive cells and rotation responses between the right- and left-sided 6-OHDA-treated groups. On the other hand, injury of rats with unilateral 6-OHDA resulted in haemodynamic, electrocardiographic, and biochemical changes. A significant difference was found between the right-sided 6-OHDA-treated rats and the left-sided treated ones. The MAP increased in the group given left 6-OHDA treatment and to lesser extent in the sham-operated group. In contrast, MAP did not increase in the group given right 6-OHDA treatment and was significantly lower than values in both the intact control rats and the sham-treated rats. Also, only the group given right 6-OHDA injury showed a fall in the value of HR. The plasma NE level was significantly decreased in the group given right 6-OHDA treatment compared with all other groups (P < 0.005). Our results indicate that right-sided lesioning of the nigrostriatal DA pathway in the central nervous system (CNS) has greater sympathetic consequences than left-sided ones. These results also suggest that there is a differential effect of right-sided SN lesions on sympathetic cardiac innervation. The mechanism behind the confronting impairment of autonomic nervous system (ANS) could in this experiment be attributable to an asymmetric representation of sympathetic function in the brain. However, further studies will be needed before final conclusions can be made.
引用
收藏
页码:281 / 292
页数:12
相关论文
共 50 条
  • [41] Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson's disease
    Morroni, Fabiana
    Sita, Giulia
    Tarozzi, Andrea
    Cantelli-Forti, Giorgio
    Hrelia, Patrizia
    BRAIN RESEARCH, 2014, 1589 : 93 - 104
  • [42] Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat:: an animal model of Parkinson's disease
    Díaz, MR
    Abdala, P
    Barroso-Chinea, P
    Obeso, J
    González-Hernández, T
    BEHAVIOURAL BRAIN RESEARCH, 2001, 122 (01) : 79 - 92
  • [43] Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson's disease
    Okkay, Irmak Ferah
    Okkay, Ufuk
    Cicek, Betul
    Yilmaz, Aysegul
    Yesilyurt, Fatma
    Mendil, Ali Sefa
    Hacimuftuoglu, Ahmet
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (12) : 7711 - 7717
  • [44] Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model
    da Fonseca, Victor Silva
    Goncalves, Valeria de Cassia
    Izidoro, Mario Augusto
    de Almeida, Antonio-Carlos Guimaraes
    Fonseca, Fernando Luiz Affonso
    Scorza, Fulvio Alexandre
    Finsterer, Josef
    Scorza, Carla Alessandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [45] Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson’s disease
    Irmak Ferah Okkay
    Ufuk Okkay
    Betul Cicek
    Aysegul Yilmaz
    Fatma Yesilyurt
    Ali Sefa Mendil
    Ahmet Hacimuftuoglu
    Molecular Biology Reports, 2021, 48 : 7711 - 7717
  • [46] Gait analysis in three different 6-hydroxydopamine rat models of Parkinson's disease
    Zhou, Ming
    Zhang, Wangming
    Chang, Jingyu
    Wang, Jun
    Zheng, Weixin
    Yang, Yong
    Wen, Peng
    Li, Min
    Xiao, Hu
    NEUROSCIENCE LETTERS, 2015, 584 : 184 - 189
  • [47] Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson's disease model
    Kim, Sang Min
    Park, Yong Joo
    Shin, Myoung-Sook
    Kim, Ha-Ryong
    Kim, Min Jae
    Lee, Sang Hun
    Yun, Seung Pil
    Kwon, Seung-Hwan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5207 - 5212
  • [48] In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease
    Casteels, Cindy
    Lauwers, Erwin
    Baitar, Abdelbari
    Bormans, Guy
    Baekelandt, Veerle
    Van Laere, Koen
    BRAIN RESEARCH, 2010, 1316 : 153 - 162
  • [49] The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
    Liu, Cheng-Tsung
    Kao, Li-Ting
    Shih, Jui-Hu
    Chien, Wu-Chien
    Chiu, Chuang-Hsin
    Ma, Kuo-Hsing
    Huang, Yuahn-Sieh
    Cheng, Cheng-Yi
    Shiue, Chyng-Yann
    Li, I-Hsu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 862
  • [50] Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson's disease
    Kim, Na-Hyun
    Goto, Yukiori
    Lee, Young-A
    PHARMACOLOGICAL REPORTS, 2025, 77 (01) : 247 - 259